Navigation Links
Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer

marized by such statements. Preliminary results may not be confirmed upon final analysis of the detailed results of a trial and additional information relating to the safety, efficacy or tolerability of Amrubicin may be discovered upon further analysis of clinical trial data and upon review and analysis of additional clinical trial data from this or other clinical trials. Additional risks and uncertainties relating to Pharmion and its business can be found in the "Risk Factors" section of Pharmion's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2007, its Annual Report on Form 10-K for the year ended December 31, 2006 and in Pharmion's other filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date on which they are made, and Pharmion undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future developments or otherwise. Pharmion also disclaims any duty to comment upon or correct information that may be contained in reports published by the investment community.

CONTACT: Breanna Burkart or Anna Sussman, Directors, Investor Relationsand Corporate Communications, +1-720-564-9144, or +1-720-564-9143, both ofPharmion Corporation; or On-site Media, Tara May, +1-303-646-7832, forPharmion Corporation

Web site: http://www.pharmion.com/

Ticker Symbol: (NASDAQ-NMS:PHRM)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
2. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
3. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
4. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
5. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
6. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
7. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
8. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
9. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
10. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
11. New Poll Shows Men, Women Incorrectly Blame Symptoms of Low Testosterone on Normal Aging
Post Your Comments:
(Date:5/27/2015)... May 27, 2015 ... senkt die Leistungsfähigkeit enorm. Es ist schwierig konzentriert ... wacht zum falschen Zeitpunkt in einem Hotelzimmer auf, ... später, nach Hause zurückgekehrt, fühlt man sich  oft ... oder dem Partner etwas zu unternehmen oder bei ...
(Date:5/26/2015)... , May 26, 2015  The National Association of ... pleased to announce that general availability for the .pharmacy ... pharmacies and pharmacy-related entities may apply for .pharmacy domain ... launched in 2014, and NABP has approved more than ... prior limited registration periods. NABP created the .pharmacy TLD ...
(Date:5/26/2015)... Mass. , May 26, 2015  Haemonetics Corporation ... Gould , Vice President, Investor Relations, will present at ... Boston on June 4 th , 2015 ... may access Mr. Gould,s presentation live via webcast at: ... Haemonetics (NYSE: HAE ) is a global healthcare ...
Breaking Medicine Technology:Jetlag schneller überwinden! Spitzen-Athleten wissen wie: Doppelt so schnell voll leistungsfähig sein mit innovativer Technik 2Jetlag schneller überwinden! Spitzen-Athleten wissen wie: Doppelt so schnell voll leistungsfähig sein mit innovativer Technik 3Jetlag schneller überwinden! Spitzen-Athleten wissen wie: Doppelt so schnell voll leistungsfähig sein mit innovativer Technik 4General Availability for .Pharmacy Domain Names Begins June 3, 2015 2
... Pharmatek Laboratories, Inc., a premier contract development and ... it has added spray drying to its drug ... a Buchi B-290 Mini Spray Dryer for formulation ... can be used for both oral and parenteral ...
... April 25, 2011 Stereotaxis, Inc. (NASDAQ: STXS ... following investor conferences during May 2011: The ... Kaminski, President and Chief Executive Officer of Stereotaxis, is scheduled ... 3, 2011 at 4:10 p.m. ET. The JMP Securities ...
Cached Medicine Technology:Pharmatek Laboratories Adds Spray Drying to Drug Development Services 2Stereotaxis to Present at Upcoming Investor Conferences 2Stereotaxis to Present at Upcoming Investor Conferences 3
(Date:5/27/2015)... May 27, 2015 The Case Management ... highest honor, the CMSA Lifetime Achievement Award, to Anne ... on Thursday, June 25th at the association’s 25th Annual ... Orlando, Florida. , The CMSA Board of Directors awards ... has made a significant contribution to practice of case ...
(Date:5/27/2015)... Connecticut (PRWEB) May 27, 2015 This year, ... mental health awareness campaign and encouraging those affected to seek ... on Mental Health (NAMI), one in five children, ages ... mental illness. Additionally, 50% of all cases of mental illness ... is suggesting, it is essential to seek help before reaching ...
(Date:5/27/2015)... Rosa Ca (PRWEB) May 27, 2015 ... University of Texas Southwestern Medical Center at Dallas some ... tunnel syndrome. Both CTS and migraine headache apparently also ... women, in incidents of obesity, people with a history ... be less common in Asians, and CTS in particular ...
(Date:5/26/2015)... Avid Collector, Andrew Hawley from ... Jimi Hendrix January 11-23, 1969 psychedelic German concert tour ... of Hendrix for this concert poster tour blank. ... known as the Hendrix with wired hair concert ... days. The tour started at the Musikhalle in ...
(Date:5/26/2015)... 26, 2015 Degeneration of the white ... of specific types of Alzheimer’s disease (AD), including early-onset ... in the journal Radiology. , “Alzheimer’s is a ... of the study conducted at the Neuroimaging Research Unit, ... matter damage has a central role in how the ...
Breaking Medicine News(10 mins):Health News:CMSA to Present Prestigious Lifetime Achievement Award to Anne Llewellyn RN-BC, MS, BHSA, CCM, CRRN 2Health News:The Glenholme School Observes Mental Health Awareness Month 2Health News:The Glenholme School Observes Mental Health Awareness Month 3Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 2Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 3Health News:Santa Rosa Orthopaedics Offers Insights into Recent Study Results Connecting Migraines with Chronic Conditions Such as Carpal Tunnel Syndrome 4Health News:Avid Collector from Vintage Rock Posters Announces His Search for Original Jimi Hendrix January 11-23, 1969 Psychedelic German Concert Tour Posters 2Health News:RSNA: Imaging Test May Identify Biomarker of Alzheimer’s Disease 2Health News:RSNA: Imaging Test May Identify Biomarker of Alzheimer’s Disease 3
... the most efficient radiation dose to pregnant patients with ... fetus, according to a study performed at SUNY ... , Simulated pulmonary and pelvic studies were performed ... range for fetal exposure using CT scanners. "The 64-slice ...
... may start drinking at a later age -- which may, ... new study suggests. , The findings, published in the May ... Drugs , underscore the important role parents play in the ... the age at which kids start drinking is a key ...
... Hospital at The University of Texas M. D. Anderson ... the growth of neuroblastoma, a childhood brain cancer. The ... at the 22nd annual meeting of the American Society ... the Children,s Cancer Hospital at M. D. Anderson, presented ...
... added the use of Mild Hyperbarics to drug and alcohol treatment program ... hyperbarics is not generally associated with drug and alcohol treatment in the ... services that meet the needs of the person in mind, body and ... ...
... Valeant Pharmaceuticals (NYSE: VRX ) today announced ... IIb dose-finding clinical trial for taribavirin, a prodrug of ... chronic hepatitis C in conjunction with a pegylated interferon, ... Study of Liver (EASL) 44th Annual Meeting in Copenhagen, ...
... at risk for developing condition , , THURSDAY, April 23 (HealthDay ... up to six times more likely to develop the disease ... and Prevention researchers. , They analyzed data on 1,500 adults, ... average, moderate or high risk of asthma based on the ...
Cached Medicine News:Health News:64-slice CT: Most dose efficient for evaluating pregnant patients with possible pulmonary emboli 2Health News:Good relationship with parents may prevent teen drinking problems 2Health News:Novel cancer drug reduces neuroblastoma growth by 75 percent 2Health News:G & G Holistic Addiction Treatment Uses Innovative Use of Oxygen Therapy Which Restores Mind and Body in Drug Rehab 2Health News:G & G Holistic Addiction Treatment Uses Innovative Use of Oxygen Therapy Which Restores Mind and Body in Drug Rehab 3Health News:Valeant Pharmaceuticals Highlights Taribavirin Phase IIb 60-Week Data Presentation at European Association for the Study of Liver (EASL) Annual Meeting 2Health News:Valeant Pharmaceuticals Highlights Taribavirin Phase IIb 60-Week Data Presentation at European Association for the Study of Liver (EASL) Annual Meeting 3Health News:Valeant Pharmaceuticals Highlights Taribavirin Phase IIb 60-Week Data Presentation at European Association for the Study of Liver (EASL) Annual Meeting 4Health News:Family History of Asthma Boosts Odds Almost 6 Times 2
... infectious disease ELISA products make us a ... protocols for faster integration into the busy ... increased reliability and run-to-run consistency. Our Infectious ... for a wide range of serological assays ...
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
... of infectious disease ELISA products make us ... assay protocols for faster integration into the ... provide increased reliability and run-to-run consistency. Our ... assays for a wide range of serological ...
... infectious disease ELISA products make us a ... protocols for faster integration into the busy ... increased reliability and run-to-run consistency. Our Infectious ... for a wide range of serological assays ...
Medicine Products: